GLOBMOD uses data, science, and technology to optimize development, financing, and adoption of health technology and programs. A service provider to the global healthcare industry, GLOBMOD analyzes effectiveness, and establishes evidence. Through its portfolio of health economics, outcomes research, market access, data analytics and epidemiology services, it partners with life sciences organizations worldwide to optimize the market access and commercial success of their products.
GLOBMOD pillars are interdisicplinarity and attention to details. Specific health-economic and market-access activities include: disease modeling, budget impact, cost-effectiveness analysis, cost-utility analysis, cost-benefit analysis, and multi criteria decision analysis (MCDA). Modeling techniques include: Decision-Trees, Markov Models, Discrete Event Simulations, Dynamical Compartmental Models, Individual-agent Based Models, and Multi-scale Network Models. Statistical and AI services include: descriptive statistic, hypothesis testing, meta-analysis, sample size calculation, cluster analysis, multivariate regressions (with Generalized Linear Regressions, and Random Forest), classification algorithms (Random Forest, and Neural Networks), Time Series Analysis, Causal Inference, and Watson Services. We also develop metrics of program and system impact. For instance, we were the first proponents (in 2013) of a new metric encompassing human and animal health, and environmental sustainability. We are currently conceptualizing the first metric of planetary health.